Irene O. Aninye, PhD, Chief Science Officer at the Society for Women’s Health Research, examines the consequences of overlooking sex and gender differences in research and clinical care.
Two major oil companies, bp and Total, are among the six new offshore wind projects that will build renewable energy stations in the waters surrounding the UK.
Tracey Lethbridge, head of UK public sector at OpenText, discusses how digital technologies could empower governments and their people during the current pandemic and beyond.
Edward Wade, Content Author and Technical SEO at Wilson Field, explores how the coronavirus pandemic has changed the insolvency landscape of the retail and hospitality sector.
The science and art of dispensing optics are ever dynamic, writes Daryl Newsome from the Association of British Dispensing Opticians. Opticians must adopt new technology, adapt their practice of dispensing and take ownership of innovation, he argues.
Zisis Kozlakidis, International Agency for Research on Cancer, with Erik Steinfelder, Thermo Fisher Scientific, chart the challenges in healthcare logistics in relation to COVID-19.
The UK government estimates that tidal power could meet around 20% of our electricity demands, an amount which could change the dynamics of energy in this country.
Edward Belgeonne, founder, & CEO Bantham Technologies, discusses how innovative technology is key to hitting net-zero and creating more time to care in the NHS.
The new results led to the South African Government suspending use of AstraZeneca in their vaccination programme, as it is no longer able to stop the mutation - but could still prevent hospitalisation and fatality.
UK based scientists witnessed how COVID-19 can mutate in a highly vulnerable patient, even when that person is undergoing convalescent plasma treatment.
Chris Girard, Associate Professor at Florida International University, explores COVID-19 and coevolving informatics, including comment on defence logic from meiosis to AI.
Recent data published by the UK’s independent medicines regulator assures the Pfizer/BioNTech and the Oxford University/AstraZeneca vaccines meet strict regulatory standards for safety
